Current perspectives on the mechanism of action of artemisinins

详细信息	查看全文 | 推荐本文 |

• 作者：Jacob Golenser ; Judith H. Waknine ; Miriam Krugliak ; Nicholas H. Hunt ; Georges E. Grau
• 关键词：Malaria treatment ; Artemisinin ; Cytokines ; SERCA ; Free radicals ; Resistance
• 刊名：International Journal for Parasitology
• 出版年：2006
• 期刊代码：124_00207519
• 类别：med
• 出版时间：December 2006
• 卷：36
• 期：14
• 页码：1427-1441
• 文件大小：587 K

摘要

Artemisinin derivatives are the most recent single drugs approved and introduced for public antimalarial treatment. Although their recommended use is for treatment of Plasmodium falciparum infection, these drugs also act against other parasites, as well as against tumor cells. The mechanisms of action attributed to artemisinin include interference with parasite transport proteins, disruption of parasite mitochondrial function, modulation of host immune function and inhibition of angiogenesis. Artemisinin combination therapies are currently the preferred treatment for malaria. These combinations may prevent the induction of parasite drug resistance. However, in view of the multiple mechanisms involved, especially when additional drugs are used, the combined therapy should be carefully examined for antagonistic effects. It is now a general theory that the crucial mechanism is interference with plasmodial SERCA. Therefore, future development of resistance may be associated with overproduction or mutations of this transporter. However, a general mechanism, such as alterations in general drug transport pathways, is feasible. In this article, we review the evidence for each mechanism of action suggested.